{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T22:05:36Z","timestamp":1794348336497,"version":"4.9.0"},"reference-count":165,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T00:00:00Z","timestamp":1761264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T00:00:00Z","timestamp":1761264000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100004339","name":"Sanofi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Am J Clin Dermatol"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s40257-025-00983-3","type":"journal-article","created":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T09:37:13Z","timestamp":1761298633000},"page":"17-47","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["The Burden of Acne Vulgaris on Health-Related Quality of Life and Psychosocial Well-Being Domains: A Systematic Review"],"prefix":"10.1007","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0473-3319","authenticated-orcid":false,"given":"Alison M.","family":"Layton","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2760-4600","authenticated-orcid":false,"given":"Vincenzo","family":"Bettoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentine","family":"Delore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9026-818X","authenticated-orcid":false,"given":"Esteban","family":"Puentes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9624-4530","authenticated-orcid":false,"given":"Jerry K. L.","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,24]]},"reference":[{"key":"983_CR1","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2015.29","volume":"1","author":"S Moradi Tuchayi","year":"2015","unstructured":"Moradi Tuchayi S, Makrantonaki E, Ganceviciene R, Dessinioti C, Feldman SR, Zouboulis CC. Acne vulgaris. Nat Rev Dis Primers. 2015;1:15029. https:\/\/doi.org\/10.1038\/nrdp.2015.29.","journal-title":"Nat Rev Dis Primers"},{"issue":"7","key":"983_CR2","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1111\/jdv.18050","volume":"36","author":"MA Richard","year":"2022","unstructured":"Richard MA, Paul C, Nijsten T, Gisondi P, Salavastru C, Taieb C, et al. Prevalence of most common skin diseases in Europe: a population-based study. J Eur Acad Dermatol Venereol. 2022;36(7):1088\u201396. https:\/\/doi.org\/10.1111\/jdv.18050.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"10440","key":"983_CR3","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.1016\/s0140-6736(24)00757-8","volume":"403","author":"GBD 2021 Diseases and Injuries Collaborators","year":"2024","unstructured":"GBD 2021 Diseases and Injuries Collaborators. Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990\u20132021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet. 2024;403(10440):2133\u201361. https:\/\/doi.org\/10.1016\/s0140-6736(24)00757-8.","journal-title":"Lancet"},{"issue":"2","key":"983_CR4","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1093\/bjd\/ljae352","volume":"192","author":"Z Zhu","year":"2025","unstructured":"Zhu Z, Zhong X, Luo Z, Liu M, Zhang H, Zheng H, et al. Global, regional, and national burdens of acne vulgaris in adolescents and young adults aged 10\u201324 years from 1990 to 2021: a trend analysis. Br J Dermatol. 2025;192(2):228\u201337. https:\/\/doi.org\/10.1093\/bjd\/ljae352.","journal-title":"Br J Dermatol"},{"issue":"2","key":"983_CR5","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1111\/bjd.19477","volume":"184","author":"AM Layton","year":"2021","unstructured":"Layton AM, Thiboutot D, Tan J. Reviewing the global burden of acne: how could we improve care to reduce the burden? Br J Dermatol. 2021;184(2):219\u201325. https:\/\/doi.org\/10.1111\/bjd.19477.","journal-title":"Br J Dermatol"},{"key":"983_CR6","unstructured":"United States Food and Drug Administration. Patient-reported outcome measures: use in medical product development to support labeling claims. 2009. https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/patient-reported-outcome-measures-use-medical-product-development-support-labeling-claims. Accessed 3 Feb 2025."},{"issue":"8","key":"983_CR7","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1111\/jdv.13776","volume":"30","author":"A Nast","year":"2016","unstructured":"Nast A, Dr\u00e9no B, Bettoli V, Bukvic Mokos Z, Degitz K, Dressler C, et al. European evidence-based (S3) guideline for the treatment of acne\u2014update 2016\u2014short version. J Eur Acad Dermatol Venereol. 2016;30(8):1261\u20138. https:\/\/doi.org\/10.1111\/jdv.13776.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"8","key":"983_CR8","doi-asserted-by":"publisher","first-page":"1784","DOI":"10.1016\/j.jid.2017.04.017","volume":"137","author":"AM Layton","year":"2017","unstructured":"Layton AM, Eady EA, Thiboutot DM, Tan J, Acne Core Outcomes Research Network (ACORN) Outcomes Identification Group. Identifying what to measure in acne clinical trials: first steps towards development of a core outcome set. J Investig Dermatol. 2017;137(8):1784\u20136. https:\/\/doi.org\/10.1016\/j.jid.2017.04.017.","journal-title":"J Investig Dermatol"},{"key":"983_CR9","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/978-3-030-68996-4_3","volume-title":"Acne: current concepts and management","author":"J Tan","year":"2021","unstructured":"Tan J, Thiboutot D, Layton A, Miklas M. Developing a core outcome set for acne clinical trials: towards standardization and harmonization. In: Suh DH, editor. Acne: current concepts and management. Springer International Publishing: Cham; 2021. p. 25\u201333. https:\/\/doi.org\/10.1007\/978-3-030-68996-4_3."},{"issue":"2","key":"983_CR10","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1111\/jdv.14585","volume":"32","author":"PV Chernyshov","year":"2018","unstructured":"Chernyshov PV, Zouboulis CC, Tomas-Aragones L, Jemec GB, Manolache L, Tzellos T, et al. Quality of life measurement in acne. Position paper of the European Academy of Dermatology and Venereology Task Forces on Quality of Life and Patient Oriented Outcomes and Acne, Rosacea and Hidradenitis Suppurativa. J Eur Acad Dermatol Venereol. 2018;32(2):194\u2013208. https:\/\/doi.org\/10.1111\/jdv.14585.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"2","key":"983_CR11","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/s40257-020-00564-6","volume":"22","author":"H Smith","year":"2021","unstructured":"Smith H, Layton AM, Thiboutot D, Smith A, Whitehouse H, Ghumra W, et al. Identifying the impacts of acne and the use of questionnaires to detect these impacts: a systematic literature review. Am J Clin Dermatol. 2021;22(2):159\u201371. https:\/\/doi.org\/10.1007\/s40257-020-00564-6.","journal-title":"Am J Clin Dermatol"},{"issue":"8","key":"983_CR12","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1001\/jamadermatol.2022.2260","volume":"158","author":"ZH Hopkins","year":"2022","unstructured":"Hopkins ZH, Thiboutot D, Homsi HA, Perez-Chada LM, Barbieri JS. Patient-reported outcome measures for health-related quality of life in patients with acne vulgaris: a systematic review of measure development and measurement properties. JAMA Dermatol. 2022;158(8):900\u201311. https:\/\/doi.org\/10.1001\/jamadermatol.2022.2260.","journal-title":"JAMA Dermatol"},{"key":"983_CR13","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71. https:\/\/doi.org\/10.1136\/bmj.n71.","journal-title":"BMJ"},{"issue":"3","key":"983_CR14","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1111\/j.1365-2230.1994.tb01167.x","volume":"19","author":"AY Finlay","year":"1994","unstructured":"Finlay AY, Khan GK. Dermatology life quality index (DLQI)\u2014a simple practical measure for routine clinical use. Clin Exp Dermatol. 1994;19(3):210\u20136. https:\/\/doi.org\/10.1111\/j.1365-2230.1994.tb01167.x.","journal-title":"Clin Exp Dermatol"},{"key":"983_CR15","unstructured":"Joanna Briggs Institute. JBI Critical Appraisal Tools. 2025. https:\/\/jbi.global\/critical-appraisal-tools. Accessed 10 Jan 2025."},{"key":"983_CR16","doi-asserted-by":"crossref","unstructured":"Moola S, Munn Z, Tufanaru C, Aromataris E, Sears K, Sfetcu R, et al. JBI manual for evidence synthesis. Chapter 7: systematic reviews of etiology and risk. 2020. https:\/\/synthesismanual.jbi.global\/. Accessed 13 Nov 2024.","DOI":"10.46658\/JBIRM-17-06"},{"issue":"10","key":"983_CR17","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.11124\/jbisrir-d-19-00099","volume":"18","author":"Z Munn","year":"2020","unstructured":"Munn Z, Barker TH, Moola S, Tufanaru C, Stern C, McArthur A, et al. Methodological quality of case series studies: an introduction to the JBI critical appraisal tool. JBI Evid Synth. 2020;18(10):2127\u201333. https:\/\/doi.org\/10.11124\/jbisrir-d-19-00099.","journal-title":"JBI Evid Synth"},{"issue":"3","key":"983_CR18","doi-asserted-by":"publisher","first-page":"378","DOI":"10.11124\/jbies-23-00268","volume":"22","author":"TH Barker","year":"2024","unstructured":"Barker TH, Habibi N, Aromataris E, Stone JC, Leonardi-Bee J, Sears K, et al. The revised JBI critical appraisal tool for the assessment of risk of bias for quasi-experimental studies. JBI Evid Synth. 2024;22(3):378\u201388. https:\/\/doi.org\/10.11124\/jbies-23-00268.","journal-title":"JBI Evid Synth"},{"issue":"3","key":"983_CR19","doi-asserted-by":"publisher","first-page":"494","DOI":"10.11124\/jbies-22-00430","volume":"21","author":"TH Barker","year":"2023","unstructured":"Barker TH, Stone JC, Sears K, Klugar M, Tufanaru C, Leonardi-Bee J, et al. The revised JBI critical appraisal tool for the assessment of risk of bias for randomized controlled trials. JBI Evid Synth. 2023;21(3):494\u2013506. https:\/\/doi.org\/10.11124\/jbies-22-00430.","journal-title":"JBI Evid Synth"},{"issue":"3","key":"983_CR20","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1097\/xeb.0000000000000062","volume":"13","author":"C Lockwood","year":"2015","unstructured":"Lockwood C, Munn Z, Porritt K. Qualitative research synthesis: methodological guidance for systematic reviewers utilizing meta-aggregation. Int J Evid Based Healthc. 2015;13(3):179\u201387. https:\/\/doi.org\/10.1097\/xeb.0000000000000062.","journal-title":"Int J Evid Based Healthc"},{"issue":"1","key":"983_CR21","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1186\/s12891-019-2619-8","volume":"20","author":"CM Goplen","year":"2019","unstructured":"Goplen CM, Verbeek W, Kang SH, Jones CA, Voaklander DC, Churchill TA, et al. Preoperative opioid use is associated with worse patient outcomes after total joint arthroplasty: a systematic review and meta-analysis. BMC Musculoskelet Disord. 2019;20(1):234. https:\/\/doi.org\/10.1186\/s12891-019-2619-8.","journal-title":"BMC Musculoskelet Disord"},{"issue":"9","key":"983_CR22","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0308463","volume":"19","author":"S Mahmud","year":"2024","unstructured":"Mahmud S, Hossain MF, Muyeed A, Nazneen S, Haque MA, Mazumder H, et al. Risk assessment and clinical implications of COVID-19 in multiple myeloma patients: a systematic review and meta-analysis. PLoS ONE. 2024;19(9):e0308463. https:\/\/doi.org\/10.1371\/journal.pone.0308463.","journal-title":"PLoS ONE"},{"issue":"11","key":"983_CR23","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.1177\/02692155241272967","volume":"38","author":"A Still","year":"2024","unstructured":"Still A, Hale L, Alam S, Morris ME, Jayakaran P. Relationships between physical activities performed under free-living conditions and non-motor symptoms in people with Parkinson\u2019s: a systematic review and meta-analysis. Clin Rehabil. 2024;38(11):1534\u201351. https:\/\/doi.org\/10.1177\/02692155241272967.","journal-title":"Clin Rehabil"},{"issue":"2","key":"983_CR24","doi-asserted-by":"publisher","first-page":"65","DOI":"10.5021\/ad.23.094","volume":"36","author":"IH Bae","year":"2024","unstructured":"Bae IH, Kwak JH, Na CH, Kim MS, Shin BS, Choi H. A comprehensive review of the acne grading scale in 2023. Ann Dermatol. 2024;36(2):65\u201373. https:\/\/doi.org\/10.5021\/ad.23.094.","journal-title":"Ann Dermatol"},{"issue":"4","key":"983_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2340\/00015555-3409","volume":"100","author":"IK Altunay","year":"2020","unstructured":"Altunay IK, \u00d6zkur E, Dalgard FJ, Gieler U, Tomas Aragones L, Lien L, et al. Psychosocial aspects of adult acne: data from 13 European countries. Acta Derm Venereol. 2020;100(4):1\u20136. https:\/\/doi.org\/10.2340\/00015555-3409.","journal-title":"Acta Derm Venereol"},{"issue":"8","key":"983_CR26","first-page":"1591","volume":"67","author":"E Andrese","year":"2016","unstructured":"Andrese E, Vata D, Porumb V, Martu C, Statescu L, Solovastru LG. New complex (\u03b1 hydroxy acids, \u03b2 hydroxy acids, niacinamide and glycerin) for local treatment of acne vulgaris. Rev Chim. 2016;67(8):1591\u20133.","journal-title":"Rev Chim"},{"issue":"7","key":"983_CR27","first-page":"21","volume":"11","author":"PV Chernyshov","year":"2018","unstructured":"Chernyshov PV, Petrenko A, Kopylova V. What health-related quality of life factors influence the decision of patients with acne to visit a dermatologist? J Clin Aesthet Dermatol. 2018;11(7):21\u20135.","journal-title":"J Clin Aesthet Dermatol"},{"key":"983_CR28","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.2147\/ppa.S131184","volume":"11","author":"K Chilicka","year":"2017","unstructured":"Chilicka K, Maj J, Panaszek B. General quality of life of patients with acne vulgaris before and after performing selected cosmetological treatments. Patient Prefer Adherence. 2017;11:1357\u201361. https:\/\/doi.org\/10.2147\/ppa.S131184.","journal-title":"Patient Prefer Adherence"},{"key":"983_CR29","doi-asserted-by":"publisher","first-page":"469","DOI":"10.2147\/ccid.S262691","volume":"13","author":"K Chilicka","year":"2020","unstructured":"Chilicka K, Rogowska AM, Szygu\u0142a R, Taradaj J. Examining quality of life after treatment with azelaic and pyruvic acid peels in women with acne vulgaris. Clin Cosmet Investig Dermatol. 2020;13:469\u201377. https:\/\/doi.org\/10.2147\/ccid.S262691.","journal-title":"Clin Cosmet Investig Dermatol"},{"issue":"5 cz 2","key":"983_CR30","doi-asserted-by":"publisher","first-page":"997","DOI":"10.36740\/WLek201905208","volume":"72","author":"MO Dashko","year":"2019","unstructured":"Dashko MO, Syzon OO, Chaplyk-Chyzho IO, Turkevych SA. Pathogenetic peculiarities of neuroendocrine and metabolic disorders in patients with acne associated with chronic stress. Wiad Lek. 2019;72(5 cz 2):997\u20131001.","journal-title":"Wiad Lek"},{"issue":"9","key":"983_CR31","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0205009","volume":"13","author":"J Davern","year":"2018","unstructured":"Davern J, O\u2019Donnell AT. Stigma predicts health-related quality of life impairment, psychological distress, and somatic symptoms in acne sufferers. PLoS ONE. 2018;13(9):e0205009. https:\/\/doi.org\/10.1371\/journal.pone.0205009.","journal-title":"PLoS ONE"},{"issue":"5","key":"983_CR32","first-page":"514","volume":"18","author":"J DuBois","year":"2019","unstructured":"DuBois J, Ong GCW, Petkar G, Almeida LMC, Chavda R, Kerrouche N, et al. Patient-reported outcomes in acne patients with skin of color using adapalene 0.3%-benzoyl peroxide 2.5%: a prospective real-world study. J Drugs Dermatol. 2019;18(5):514.","journal-title":"J Drugs Dermatol"},{"issue":"Suppl 7","key":"983_CR33","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1111\/jdv.18917","volume":"37","author":"P Gisondi","year":"2023","unstructured":"Gisondi P, Puig L, Richard MA, Paul C, Nijsten T, Taieb C, et al. Quality of life and stigmatization in people with skin diseases in Europe: a large survey from the \u2018burden of skin diseases\u2019 EADV project. J Eur Acad Dermatol Venereol. 2023;37(Suppl 7):6\u201314. https:\/\/doi.org\/10.1111\/jdv.18917.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"2","key":"983_CR34","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1159\/000362809","volume":"229","author":"G Fabbrocini","year":"2014","unstructured":"Fabbrocini G, Izzo R, Donnarumma M, Marasca C, Monfrecola G. Acne smart club: an educational program for patients with acne. Dermatology. 2014;229(2):136\u201340. https:\/\/doi.org\/10.1159\/000362809.","journal-title":"Dermatology"},{"issue":"4","key":"983_CR35","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1590\/abd1806-4841.20175645","volume":"92","author":"K Fran\u00e7a","year":"2017","unstructured":"Fran\u00e7a K, Keri J. Psychosocial impact of acne and postinflammatory hyperpigmentation. An Bras Dermatol. 2017;92(4):505\u20139. https:\/\/doi.org\/10.1590\/abd1806-4841.20175645.","journal-title":"An Bras Dermatol"},{"issue":"6","key":"983_CR36","doi-asserted-by":"publisher","DOI":"10.3390\/cosmetics10060146","volume":"10","author":"M Grimaldi","year":"2023","unstructured":"Grimaldi M, Micali G, Bettoli V, Odorici G, Potenza C, Musumeci ML, et al. The impact of COVID-19 pandemic on acne patients and their management: an observational multicenter study from Italy. Cosmet. 2023;10(6):11. https:\/\/doi.org\/10.3390\/cosmetics10060146.","journal-title":"Cosmet"},{"issue":"10","key":"983_CR37","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12103592","volume":"12","author":"B Jankowska","year":"2023","unstructured":"Jankowska B, Zujko ME. The effectiveness of pyruvic acid peeling in improving the quality of life of patients with acne vulgaris. J Clin Med. 2023;12(10):3592. https:\/\/doi.org\/10.3390\/jcm12103592.","journal-title":"J Clin Med"},{"issue":"12","key":"983_CR38","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1111\/ddg.12889","volume":"14","author":"JT Kainz","year":"2016","unstructured":"Kainz JT, Berghammer G, Auer-Grumbach P, Lackner V, Perl-Convalexius S, Popa R, et al. Azelaic acid 20% cream: effects on quality of life and disease severity in adult female acne patients. JDDG J Dtsch Dermatol Ges. 2016;14(12):1249\u201359. https:\/\/doi.org\/10.1111\/ddg.12889.","journal-title":"JDDG J Dtsch Dermatol Ges"},{"issue":"11","key":"983_CR39","doi-asserted-by":"publisher","first-page":"1900","DOI":"10.1111\/jdv.14477","volume":"31","author":"L Lukaviciute","year":"2017","unstructured":"Lukaviciute L, Navickas P, Navickas A, Grigaitiene J, Ganceviciene R, Zouboulis CC. Quality of life, anxiety prevalence, depression symptomatology and suicidal ideation among acne patients in Lithuania. J Eur Acad Dermatol Venereol. 2017;31(11):1900\u20136. https:\/\/doi.org\/10.1111\/jdv.14477.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"17","key":"983_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2340\/00015555-3636","volume":"100","author":"E Mart\u00ednez-Garc\u00eda","year":"2020","unstructured":"Mart\u00ednez-Garc\u00eda E, Arias-Santiago S, Herrera-Acosta E, Affleck A, Herrera-Ceballos E, Buend\u00eda-Eisman A. Quality of life of cohabitants of people living with acne. Acta Derm Venereol. 2020;100(17):1\u20136. https:\/\/doi.org\/10.2340\/00015555-3636.","journal-title":"Acta Derm Venereol"},{"issue":"5","key":"983_CR41","doi-asserted-by":"publisher","first-page":"3","DOI":"10.5070\/D3255044060","volume":"25","author":"N Nagpal","year":"2019","unstructured":"Nagpal N, Gordon-Elliott J, Lipner S. Comparison of quality of life and illness perception among patients with acne, eczema, and psoriasis. Dermatol Online J. 2019;25(5):3. https:\/\/doi.org\/10.5070\/D3255044060.","journal-title":"Dermatol Online J"},{"issue":"3","key":"983_CR42","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1159\/000520447","volume":"6","author":"C Neumeister","year":"2021","unstructured":"Neumeister C, B\u00f6deker RH, Schwantes U, Borelli C. Impact of parallel topical treatment with nadifloxacin and adapalene on acne vulgaris severity and quality of life: a prospective, uncontrolled, multicentric, noninterventional study. Biomed Hub. 2021;6(3):158\u201371. https:\/\/doi.org\/10.1159\/000520447.","journal-title":"Biomed Hub."},{"issue":"1","key":"983_CR43","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1111\/jdv.13757","volume":"31","author":"C Richter","year":"2017","unstructured":"Richter C, Trojahn C, Hillmann K, Dobos G, Kanti V, Vogt A, et al. Sensitivity to change of the Dermatology Life Quality Index in adult females with facial acne vulgaris: a validation study. J Eur Acad Dermatol Venereol. 2017;31(1):169\u201374. https:\/\/doi.org\/10.1111\/jdv.13757.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"4","key":"983_CR44","doi-asserted-by":"publisher","first-page":"478","DOI":"10.2340\/00015555-2561","volume":"97","author":"F Sampogna","year":"2017","unstructured":"Sampogna F, Abeni D, Gieler U, Tomas-Aragones L, Lien L, Titeca G, et al. Impairment of sexual life in 3,485 dermatological outpatients from a multicentre study in 13 European countries. Acta Derm Venereol. 2017;97(4):478\u201382. https:\/\/doi.org\/10.2340\/00015555-2561.","journal-title":"Acta Derm Venereol"},{"issue":"6","key":"983_CR45","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.5114\/ada.2021.112765","volume":"39","author":"M Szepietowska","year":"2022","unstructured":"Szepietowska M, D\u0105browska A, Nowak B, Skinderowicz K, Wilczy\u0144ski B, Krajewski PK, et al. Prevalence and quality of life of facial acne: a cross-sectional study in high school students in Poland. Adv Dermatol Allergol. 2022;39(6):1035\u20139. https:\/\/doi.org\/10.5114\/ada.2021.112765.","journal-title":"Adv Dermatol Allergol"},{"issue":"1","key":"983_CR46","doi-asserted-by":"publisher","first-page":"4","DOI":"10.3390\/jcm13010004","volume":"13","author":"M Szepietowska","year":"2023","unstructured":"Szepietowska M, Stefaniak AA, Krajewski PK, Matusiak L. Females may have less severe acne, but they suffer more: a prospective cross-sectional study on psychosocial consequences in 104 consecutive Polish acne patients. J Clin Med. 2023;13(1):4. https:\/\/doi.org\/10.3390\/jcm13010004.","journal-title":"J Clin Med"},{"key":"983_CR47","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.jdin.2021.03.002","volume":"3","author":"J Tan","year":"2021","unstructured":"Tan J, Beissert S, Cook-Bolden F, Chavda R, Harper J, Hebert A, et al. Impact of facial and truncal acne on quality of life: a multi-country population-based survey. JAAD Int. 2021;3:102\u201310. https:\/\/doi.org\/10.1016\/j.jdin.2021.03.002.","journal-title":"JAAD Int"},{"issue":"3","key":"983_CR48","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.anpede.2023.08.007","volume":"99","author":"L Campos-Mu\u00f1oz","year":"2023","unstructured":"Campos-Mu\u00f1oz L, Belmar Madrid C, Conde-Taboada A, Iglesias Puzas A, Gonzalez Guerra E, L\u00f3pez-Bran E. Quality of life in children with skin disease: a Spanish sample. An Pediatr (Engl Ed). 2023;99(3):170\u20135. https:\/\/doi.org\/10.1016\/j.anpede.2023.08.007.","journal-title":"An Pediatr (Engl Ed)"},{"issue":"4","key":"983_CR49","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0250155","volume":"16","author":"MR \u0110urovi\u0107","year":"2021","unstructured":"\u0110urovi\u0107 MR, \u0110urovi\u0107 M, Jankovi\u0107 J, Jankovi\u0107 S. Quality of life in Montenegrin pupils with acne. PLoS ONE. 2021;16(4):e0250155. https:\/\/doi.org\/10.1371\/journal.pone.0250155.","journal-title":"PLoS ONE"},{"issue":"7","key":"983_CR50","doi-asserted-by":"publisher","first-page":"634","DOI":"10.2298\/vsp1407634r","volume":"71","author":"V Relji\u0107","year":"2014","unstructured":"Relji\u0107 V, Maksimovi\u0107 N, Jankovi\u0107 J, Mijovi\u0107 B, Peri\u0107 J, Jankovi\u0107 S. Evaluation of the quality of life in adolescents with acne. Vojnosanit Pregl. 2014;71(7):634\u20138. https:\/\/doi.org\/10.2298\/vsp1407634r.","journal-title":"Vojnosanit Pregl"},{"issue":"6","key":"983_CR51","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1111\/j.1365-2133.1995.tb16953.x","volume":"132","author":"MS Lewis-Jones","year":"1995","unstructured":"Lewis-Jones MS, Finlay AY. The children\u2019s dermatology life quality index (CDLQI): initial validation and practical use. Br J Dermatol. 1995;132(6):942\u20139. https:\/\/doi.org\/10.1111\/j.1365-2133.1995.tb16953.x.","journal-title":"Br J Dermatol"},{"issue":"2","key":"983_CR52","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1046\/j.1365-2133.2003.05157.x","volume":"148","author":"SA Holme","year":"2003","unstructured":"Holme SA, Man I, Sharpe JL, Dykes PJ, Lewis-Jones MS, Finlay AY. The children\u2019s dermatology life quality index: validation of the cartoon version. Br J Dermatol. 2003;148(2):285\u201390. https:\/\/doi.org\/10.1046\/j.1365-2133.2003.05157.x.","journal-title":"Br J Dermatol"},{"key":"983_CR53","doi-asserted-by":"publisher","DOI":"10.2340\/actadv.v104.41120","volume":"104","author":"J Vyas","year":"2024","unstructured":"Vyas J, Johns JR, Ali FM, Ingram JR, Salek S, Finlay AY. A systematic review of 207 studies describing validation aspects of the Dermatology Life Quality Index. Acta Derm Venereol. 2024;104:adv41120. https:\/\/doi.org\/10.2340\/actadv.v104.41120.","journal-title":"Acta Derm Venereol"},{"issue":"3","key":"983_CR54","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1093\/bjd\/ljad079","volume":"190","author":"J Vyas","year":"2024","unstructured":"Vyas J, Johns JR, Ali FM, Singh RK, Ingram JR, Salek S, et al. A systematic review of 454 randomized controlled trials using the Dermatology Life Quality Index: experience in 69 diseases and 43 countries. Br J Dermatol. 2024;190(3):315\u201339. https:\/\/doi.org\/10.1093\/bjd\/ljad079.","journal-title":"Br J Dermatol"},{"issue":"4","key":"983_CR55","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1111\/bjd.12437","volume":"169","author":"MS Salek","year":"2013","unstructured":"Salek MS, Jung S, Brincat-Ruffini LA, MacFarlane L, Lewis-Jones MS, Basra MK, et al. Clinical experience and psychometric properties of the Children\u2019s Dermatology Life Quality Index (CDLQI), 1995\u20132012. Br J Dermatol. 2013;169(4):734\u201359. https:\/\/doi.org\/10.1111\/bjd.12437.","journal-title":"Br J Dermatol"},{"issue":"5","key":"983_CR56","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1111\/j.1365-2133.2008.08832.x","volume":"159","author":"MK Basra","year":"2008","unstructured":"Basra MK, Fenech R, Gatt RM, Salek MS, Finlay AY. The Dermatology Life Quality Index 1994\u20132007: a comprehensive review of validation data and clinical results. Br J Dermatol. 2008;159(5):997\u20131035. https:\/\/doi.org\/10.1111\/j.1365-2133.2008.08832.x.","journal-title":"Br J Dermatol"},{"issue":"7","key":"983_CR57","first-page":"19","volume":"7","author":"VD Callender","year":"2014","unstructured":"Callender VD, Alexis AF, Daniels SR, Kawata AK, Burk CT, Wilcox TK, et al. Racial differences in clinical characteristics, perceptions and behaviors, and psychosocial impact of adult female acne. J Clin Aesthet Dermatol. 2014;7(7):19\u201331.","journal-title":"J Clin Aesthet Dermatol."},{"issue":"3","key":"983_CR58","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1097\/jdn.0000000000000129","volume":"7","author":"J Gorelick","year":"2015","unstructured":"Gorelick J, Daniels SR, Kawata AK, Degboe A, Wilcox TK, Burk CT, et al. Acne-related quality of life among female adults of different races\/ethnicities. J Dermatol Nurses Assoc. 2015;7(3):154\u201362. https:\/\/doi.org\/10.1097\/jdn.0000000000000129.","journal-title":"J Dermatol Nurses Assoc"},{"issue":"2","key":"983_CR59","first-page":"22","volume":"7","author":"EA Tanghetti","year":"2014","unstructured":"Tanghetti EA, Kawata AK, Daniels SR, Yeomans K, Burk CT, Callender VD. Understanding the burden of adult female acne. J Clin Aesthet Dermatol. 2014;7(2):22\u201330.","journal-title":"J Clin Aesthet Dermatol"},{"issue":"11","key":"983_CR60","first-page":"1147","volume":"18","author":"JC Harper","year":"2019","unstructured":"Harper JC, Baldwin H, Stein Gold L, Guenin E. Efficacy and tolerability of a novel tretinoin 0.05% lotion for the once-daily treatment of moderate or severe acne vulgaris in adult females. J Drugs Dermatol. 2019;18(11):1147\u201354.","journal-title":"J Drugs Dermatol"},{"issue":"3","key":"983_CR61","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2019-034047","volume":"11","author":"S Hornsey","year":"2021","unstructured":"Hornsey S, Stuart B, Muller I, Layton AM, Morrison L, King J, et al. Patient-reported outcome measures for acne: a mixed-methods validation study (acne PROMs). BMJ Open. 2021;11(3):e034047. https:\/\/doi.org\/10.1136\/bmjopen-2019-034047.","journal-title":"BMJ Open"},{"issue":"11","key":"983_CR62","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.36849\/jdd.2020.5457","volume":"19","author":"LH Kircik","year":"2020","unstructured":"Kircik LH, Lain E, Gold M, Katz B, Baldwin H, Guenin E, et al. Effects of tazarotene 0.045% lotion on quality of life in patients with moderate-to-severe acne. J Drugs Dermatol. 2020;19(11):1086\u201392. https:\/\/doi.org\/10.36849\/jdd.2020.5457.","journal-title":"J Drugs Dermatol"},{"key":"983_CR63","doi-asserted-by":"publisher","first-page":"145","DOI":"10.15405\/epsbs.2015.01.17","volume":"2","author":"J Liasides","year":"2015","unstructured":"Liasides J, Apergi FS. Predictors of quality of life in adults with acne: the contribution of perceived stigma. Eur Proc Soc Behav Sci. 2015;2:145\u201355. https:\/\/doi.org\/10.15405\/epsbs.2015.01.17.","journal-title":"Eur Proc Soc Behav Sci."},{"issue":"3","key":"983_CR64","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1177\/1203475417743232","volume":"22","author":"C McLellan","year":"2018","unstructured":"McLellan C, Frey MP, Tan J. Assessing the need for a comprehensive acne quality-of-life scale for face and torso acne. J Cutan Med Surg. 2018;22(3):263\u20136. https:\/\/doi.org\/10.1177\/1203475417743232.","journal-title":"J Cutan Med Surg"},{"issue":"12","key":"983_CR65","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2023-073245","volume":"13","author":"S Pyne","year":"2023","unstructured":"Pyne S, Sach TH, Lawrence M, Renz S, Eminton Z, Stuart B, et al. Cost-effectiveness of spironolactone for adult female acne (SAFA): economic evaluation alongside a randomised controlled trial. BMJ Open. 2023;13(12):e073245. https:\/\/doi.org\/10.1136\/bmjopen-2023-073245.","journal-title":"BMJ Open"},{"key":"983_CR66","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2022-074349","volume":"381","author":"M Santer","year":"2023","unstructured":"Santer M, Lawrence M, Renz S, Eminton Z, Stuart B, Sach TH, et al. Effectiveness of spironolactone for women with acne vulgaris (SAFA) in England and Wales: pragmatic, multicentre, phase 3, double blind, randomised controlled trial. BMJ. 2023;381:e074349. https:\/\/doi.org\/10.1136\/bmj-2022-074349.","journal-title":"BMJ"},{"issue":"1","key":"983_CR67","first-page":"21","volume":"11","author":"N Skroza","year":"2018","unstructured":"Skroza N, Tolino E, Mambrin A, Zuber S, Balduzzi V, Marchesiello A, et al. Adult acne versus adolescent acne: a retrospective study of 1,167 patients. J Clin Aesthet Dermatol. 2018;11(1):21\u20135.","journal-title":"J Clin Aesthet Dermatol."},{"issue":"12","key":"983_CR68","first-page":"1218","volume":"18","author":"L Stein Gold","year":"2019","unstructured":"Stein Gold L, Pariser DM, Guenin E. Tretinoin 0.05% lotion for the once-daily treatment of moderate and severe acne vulgaris in females: effect of age on efficacy and tolerability. J Drugs Dermatol. 2019;18(12):1218\u201325.","journal-title":"J Drugs Dermatol"},{"issue":"10","key":"983_CR69","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.36849\/jdd.7812","volume":"22","author":"L Stein Gold","year":"2023","unstructured":"Stein Gold L, Harding G, Borroto D, Choudhury SP, Dutta SK, Pharm DT, et al. Post-hoc exploratory pooled analysis of the impact of IDP-126 gel on QoL in moderate-to-severe acne. J Drugs Dermatol. 2023;22(10):1033\u20139. https:\/\/doi.org\/10.36849\/jdd.7812.","journal-title":"J Drugs Dermatol"},{"issue":"5","key":"983_CR70","first-page":"56","volume":"14","author":"E Tolino","year":"2021","unstructured":"Tolino E, Skroza N, Mambrin A, Proietti I, Bernardini N, Balduzzi V, et al. An open-label study comparing oral zinc to lymecycline in the treatment of acne vulgaris. J Clin Aesthet Dermatol. 2021;14(5):56\u20138.","journal-title":"J Clin Aesthet Dermatol."},{"issue":"6","key":"983_CR71","doi-asserted-by":"publisher","DOI":"10.1111\/dth.14392","volume":"33","author":"E Tolino","year":"2020","unstructured":"Tolino E, Skroza N, Proietti I, Mambrin A, Balduzzi V, Marchesiello A, et al. Efficacy and safety of systemic isotretinoin treatment for moderate to severe acne (insights from the real-life clinical setting). Dermatol Ther. 2020;33(6):e14392. https:\/\/doi.org\/10.1111\/dth.14392.","journal-title":"Dermatol Ther"},{"issue":"6","key":"983_CR72","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1007\/s40257-020-00559-3","volume":"21","author":"SK Tyring","year":"2020","unstructured":"Tyring SK, Kircik L, Pariser DM, Woolery-Lloyd HC, Harper JC, Bhatt V, et al. The effects of once-daily tretinoin 0.05% lotion on quality of life in patients with moderate-to-severe acne vulgaris. Am J Clin Dermatol. 2020;21(6):891\u20139. https:\/\/doi.org\/10.1007\/s40257-020-00559-3.","journal-title":"Am J Clin Dermatol"},{"issue":"9","key":"983_CR73","first-page":"15","volume":"13","author":"AL Zaenglein","year":"2020","unstructured":"Zaenglein AL, Segal J, Darby C, Del Rosso JQ. Lidose-isotretinoin administered without food improves quality of life in patients with severe recalcitrant nodular acne: an open-label, single-arm, phase IV study. J Clin Aesthet Dermatol. 2020;13(9):15\u201320.","journal-title":"J Clin Aesthet Dermatol."},{"issue":"5","key":"983_CR74","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1007\/bf00540020","volume":"5","author":"CJ Girman","year":"1996","unstructured":"Girman CJ, Hartmaier S, Thiboutot D, Johnson J, Barber B, DeMuro-Mercon C, et al. Evaluating health-related quality of life in patients with facial acne: development of a self-administered questionnaire for clinical trials. Qual Life Res. 1996;5(5):481\u201390. https:\/\/doi.org\/10.1007\/bf00540020.","journal-title":"Qual Life Res"},{"issue":"5","key":"983_CR75","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1046\/j.1365-2230.2001.00839.x","volume":"26","author":"AR Martin","year":"2001","unstructured":"Martin AR, Lookingbill DP, Botek A, Light J, Thiboutot D, Girman CJ. Health-related quality of life among patients with facial acne\u2014assessment of a new acne-specific questionnaire. Clin Exp Dermatol. 2001;26(5):380\u20135. https:\/\/doi.org\/10.1046\/j.1365-2230.2001.00839.x.","journal-title":"Clin Exp Dermatol"},{"issue":"5","key":"983_CR76","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1111\/jocd.15609","volume":"22","author":"S Cretu","year":"2023","unstructured":"Cretu S, Dascalu M, Salavastru CM. Validation of the Cardiff Acne Disability Index and the impact of educational materials in a Romanian cultural adaptation context. J Cosmet Dermatol. 2023;22(5):1595\u2013601. https:\/\/doi.org\/10.1111\/jocd.15609.","journal-title":"J Cosmet Dermatol"},{"issue":"2","key":"983_CR77","doi-asserted-by":"publisher","DOI":"10.1002\/hsr2.487","volume":"5","author":"F de Vries","year":"2022","unstructured":"de Vries F, Driessen R, Tjin E, Westenberg A, Vehof H, van de Kerkhof P. The association between acne care provision and quality of life: a cross-sectional survey. Health Sci Rep. 2022;5(2):e487. https:\/\/doi.org\/10.1002\/hsr2.487.","journal-title":"Health Sci Rep"},{"issue":"9","key":"983_CR78","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2017-016964","volume":"7","author":"KP Desai","year":"2017","unstructured":"Desai KP, Martyn-Simmons C, Viner R, Segal TY. Help-seeking behaviours, opportunistic treatment and psychological implications of adolescent acne: cross-sectional studies in schools and hospital outpatient departments in the UK. BMJ Open. 2017;7(9):e016964. https:\/\/doi.org\/10.1136\/bmjopen-2017-016964.","journal-title":"BMJ Open"},{"issue":"6","key":"983_CR79","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1111\/jdv.12757","volume":"29","author":"B Dr\u00e9no","year":"2015","unstructured":"Dr\u00e9no B, Thiboutot D, Layton AM, Berson D, Perez M, Kang S. Large-scale international study enhances understanding of an emerging acne population: adult females. J Eur Acad Dermatol Venereol. 2015;29(6):1096\u2013106. https:\/\/doi.org\/10.1111\/jdv.12757.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"5","key":"983_CR80","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1111\/jdv.15419","volume":"33","author":"B Dr\u00e9no","year":"2019","unstructured":"Dr\u00e9no B, Bordet C, Seite S, Taieb C. Acne relapses: impact on quality of life and productivity. J Eur Acad Dermatol Venereol. 2019;33(5):937\u201343. https:\/\/doi.org\/10.1111\/jdv.15419.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"S4","key":"983_CR81","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1111\/jdv.13195","volume":"29","author":"HP Gollnick","year":"2015","unstructured":"Gollnick HP, Friedrich M, Peschen M, Pettker R, Pier A, Streit V, et al. Effect of adapalene 0.1%\/benzoyl peroxide 2.5% topical gel on quality of life and treatment adherence during long-term application in patients with predominantly moderate acne with or without concomitant medication\u2014additional results from the non-interventional cohort study ELANG. J Eur Acad Dermatol Venereol. 2015;29(S4):23\u20139. https:\/\/doi.org\/10.1111\/jdv.13195.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"2","key":"983_CR82","first-page":"139","volume":"26","author":"T Pochynok","year":"2018","unstructured":"Pochynok T, Chernyshov IP, Asayevich N, Sushko S, Kopylova V, Chernyshov PV. Quality of life of school and university students with acne. Acta Dermatovenerol Croat. 2018;26(2):139\u201345.","journal-title":"Acta Dermatovenerol Croat"},{"key":"983_CR83","doi-asserted-by":"publisher","first-page":"187","DOI":"10.2147\/ccid.S81691","volume":"8","author":"K Pol\u00e1kov\u00e1","year":"2015","unstructured":"Pol\u00e1kov\u00e1 K, Fauger A, Sayag M, Jourdan E. A dermocosmetic containing bakuchiol, Ginkgo biloba extract and mannitol improves the efficacy of adapalene in patients with acne vulgaris: result from a controlled randomized trial. Clin Cosmet Investig Dermatol. 2015;8:187\u201391. https:\/\/doi.org\/10.2147\/ccid.S81691.","journal-title":"Clin Cosmet Investig Dermatol"},{"issue":"1","key":"983_CR84","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1365-2230.1992.tb02521.x","volume":"17","author":"RJ Motley","year":"1992","unstructured":"Motley RJ, Finlay AY. Practical use of a disability index in the routine management of acne. Clin Exp Dermatol. 1992;17(1):1\u20133. https:\/\/doi.org\/10.1111\/j.1365-2230.1992.tb02521.x.","journal-title":"Clin Exp Dermatol"},{"issue":"4","key":"983_CR85","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1111\/bjd.20391","volume":"185","author":"YT Abdelrazik","year":"2021","unstructured":"Abdelrazik YT, Ali FM, Salek MS, Finlay AY. Clinical experience and psychometric properties of the Cardiff Acne Disability Index (CADI). Br J Dermatol. 2021;185(4):711\u201324. https:\/\/doi.org\/10.1111\/bjd.20391.","journal-title":"Br J Dermatol"},{"issue":"1","key":"983_CR86","doi-asserted-by":"publisher","first-page":"12","DOI":"10.5114\/pdia.2014.40654","volume":"31","author":"K Janowski","year":"2014","unstructured":"Janowski K, Steuden S, Bereza B. The Polish version of Skindex-29: psychometric properties of an instrument to measure quality of life in dermatology. Postep Dermatol Alergol. 2014;31(1):12\u201320. https:\/\/doi.org\/10.5114\/pdia.2014.40654.","journal-title":"Postep Dermatol Alergol."},{"issue":"2","key":"983_CR87","first-page":"120","volume":"25","author":"JD Milutinovi\u0107","year":"2017","unstructured":"Milutinovi\u0107 JD, Krsti\u0107 N, Jankovi\u0107 SM. Translation and validation of the Serbian version of the Skindex-29 instrument for measuring impact of skin disease on quality of life. Acta Dermatovenerol Croat. 2017;25(2):120\u20137.","journal-title":"Acta Dermatovenerol Croat"},{"issue":"3","key":"983_CR88","first-page":"303","volume":"150","author":"C Pagliarello","year":"2015","unstructured":"Pagliarello C, Di Pietro C, Tabolli S. A comprehensive health impact assessment and determinants of quality of life, health and psychological status in acne patients. G Ital Dermatol Venereol. 2015;150(3):303\u20138.","journal-title":"G Ital Dermatol Venereol"},{"issue":"2","key":"983_CR89","doi-asserted-by":"publisher","DOI":"10.2196\/25918","volume":"4","author":"A Ip","year":"2021","unstructured":"Ip A, Muller I, Geraghty AWA, Rumsby K, Stuart B, Little P, et al. Supporting self-management among young people with acne vulgaris through a web-based behavioral intervention: development and feasibility randomized controlled trial. JMIR Dermatol. 2021;4(2):e25918. https:\/\/doi.org\/10.2196\/25918.","journal-title":"JMIR Dermatol."},{"issue":"10","key":"983_CR90","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1001\/jamadermatol.2020.2330","volume":"156","author":"AM Secrest","year":"2020","unstructured":"Secrest AM, Hopkins ZH, Frost ZE, Taliercio VL, Edwards LD, Biber JE, et al. Quality of life assessed using Skindex-16 scores among patients with acne receiving isotretinoin treatment. JAMA Dermatol. 2020;156(10):1098\u2013106. https:\/\/doi.org\/10.1001\/jamadermatol.2020.2330.","journal-title":"JAMA Dermatol"},{"issue":"4","key":"983_CR91","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1111\/pde.14034","volume":"37","author":"LM Sadowsky","year":"2020","unstructured":"Sadowsky LM, Yang CY, Sorrell J, Bayers S, O\u2019Neill LB, Chamlin SL, et al. Comparing clinical acne vulgaris severity to adolescent and parent perceptions of acne severity and impact on quality of life. Pediatr Dermatol. 2020;37(4):592\u20136. https:\/\/doi.org\/10.1111\/pde.14034.","journal-title":"Pediatr Dermatol"},{"issue":"11","key":"983_CR92","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1001\/archderm.1997.03890470111018","volume":"133","author":"MM Chren","year":"1997","unstructured":"Chren MM, Lasek RJ, Flocke SA, Zyzanski SJ. Improved discriminative and evaluative capability of a refined version of Skindex, a quality-of-life instrument for patients with skin diseases. Arch Dermatol. 1997;133(11):1433\u201340.","journal-title":"Arch Dermatol"},{"key":"983_CR93","doi-asserted-by":"publisher","unstructured":"Chren MM. The Skindex instruments to measure the effects of skin disease on quality of life. Dermatol Clin. 2012;30(2):231\u20136, xiii. https:\/\/doi.org\/10.1016\/j.det.2011.11.003.","DOI":"10.1016\/j.det.2011.11.003"},{"issue":"2","key":"983_CR94","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/bf02737863","volume":"5","author":"MM Chren","year":"2001","unstructured":"Chren MM, Lasek RJ, Sahay AP, Sands LP. Measurement properties of Skindex-16: a brief quality-of-life measure for patients with skin diseases. J Cutan Med Surg. 2001;5(2):105\u201310. https:\/\/doi.org\/10.1007\/bf02737863.","journal-title":"J Cutan Med Surg"},{"issue":"8","key":"983_CR95","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1001\/archdermatol.2010.161","volume":"146","author":"AC Smidt","year":"2010","unstructured":"Smidt AC, Lai JS, Cella D, Patel S, Mancini AJ, Chamlin SL. Development and validation of Skindex-Teen, a quality-of-life instrument for adolescents with skin disease. Arch Dermatol. 2010;146(8):865\u20139. https:\/\/doi.org\/10.1001\/archdermatol.2010.161.","journal-title":"Arch Dermatol"},{"issue":"5","key":"983_CR96","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1038\/jid.2009.404","volume":"130","author":"CA Prinsen","year":"2010","unstructured":"Prinsen CA, Lindeboom R, Sprangers MA, Legierse CM, de Korte J. Health-related quality of life assessment in dermatology: interpretation of Skindex-29 scores using patient-based anchors. J Investig Dermatol. 2010;130(5):1318\u201322. https:\/\/doi.org\/10.1038\/jid.2009.404.","journal-title":"J Investig Dermatol"},{"issue":"9","key":"983_CR97","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1038\/jid.2011.138","volume":"131","author":"CA Prinsen","year":"2011","unstructured":"Prinsen CA, Lindeboom R, de Korte J. Interpretation of Skindex-29 scores: cutoffs for mild, moderate, and severe impairment of health-related quality of life. J Investig Dermatol. 2011;131(9):1945\u20137. https:\/\/doi.org\/10.1038\/jid.2011.138.","journal-title":"J Investig Dermatol"},{"issue":"3","key":"983_CR98","first-page":"230","volume":"151","author":"G Stinco","year":"2016","unstructured":"Stinco G, Piccirillo F, Valent F, Errichetti E, Di Meo N, Trevisan G, et al. Efficacy, tolerability, impact on quality of life and sebostatic activity of three topical preparations for the treatment of mild to moderate facial acne vulgaris. G Ital Dermatol Venereol. 2016;151(3):230\u20138.","journal-title":"G Ital Dermatol Venereol"},{"issue":"3","key":"983_CR99","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/j.jand.2013.11.010","volume":"114","author":"J Burris","year":"2014","unstructured":"Burris J, Rietkerk W, Woolf K. Relationships of self-reported dietary factors and perceived acne severity in a cohort of New York young adults. J Acad Nutr Diet. 2014;114(3):384\u201392. https:\/\/doi.org\/10.1016\/j.jand.2013.11.010.","journal-title":"J Acad Nutr Diet"},{"issue":"Suppl 2","key":"983_CR100","first-page":"104","volume":"29","author":"D \u0160imi\u0107","year":"2017","unstructured":"\u0160imi\u0107 D, Penavi\u0107 JZ, Babi\u0107 D, Gunari\u0107 A. Psychological status and quality of life in acne patients treated with oral isotretinoin. Psychiatr Danub. 2017;29(Suppl 2):104\u201310.","journal-title":"Psychiatr Danub"},{"issue":"1","key":"983_CR101","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1111\/jdv.12053","volume":"28","author":"S Zauli","year":"2014","unstructured":"Zauli S, Caracciolo S, Borghi A, Ricci M, Giari S, Virgili A, et al. Which factors influence quality of life in acne patients? J Eur Acad Dermatol Venereol. 2014;28(1):46\u201350. https:\/\/doi.org\/10.1111\/jdv.12053.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"5","key":"983_CR102","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1111\/jdv.17134","volume":"35","author":"B Dr\u00e9no","year":"2021","unstructured":"Dr\u00e9no B, Khammari A, Seit\u00e9 S, Legrand C, Halioua B, Misery L, et al. Impact of acne on the daily life of adult patients: building a self-administered patient questionnaire. J Eur Acad Dermatol Venereol. 2021;35(5):1212\u20138. https:\/\/doi.org\/10.1111\/jdv.17134.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"2","key":"983_CR103","doi-asserted-by":"publisher","first-page":"SF405634s12\u2013SFs","DOI":"10.36849\/jdd.Sf405634","volume":"23","author":"HE Baldwin","year":"2024","unstructured":"Baldwin HE, Graber E, Harper JC, Alexis AF, SteinGold L, Kircik L, et al. Sarecycline improves acne severity, symptoms, and psychosocial burden in non-nodular acne vulgaris: PROSES study. J Drugs Dermatol. 2024;23(2):SF405634s12-SFs18. https:\/\/doi.org\/10.36849\/jdd.Sf405634.","journal-title":"J Drugs Dermatol"},{"issue":"2 Suppl 1","key":"983_CR104","first-page":"s5","volume":"23","author":"E Graber","year":"2024","unstructured":"Graber E, Baldwin HE, Fried RG, Rieder EA, Hebert AA, Del Rosso J, et al. Impact of acne vulgaris and sarecycline on social\/emotional functioning and daily activities: PROSES study. J Drugs Dermatol. 2024;23(2 Suppl 1):s5-11.","journal-title":"J Drugs Dermatol"},{"issue":"1","key":"983_CR105","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1111\/bjd.15853","volume":"178","author":"MKA Basra","year":"2018","unstructured":"Basra MKA, Salek MS, Fenech D, Finlay AY. Conceptualization, development and validation of T-QoL\u00a9 (Teenagers\u2019 Quality of Life): a patient-focused measure to assess quality of life of adolescents with skin diseases. Br J Dermatol. 2018;178(1):161\u201375. https:\/\/doi.org\/10.1111\/bjd.15853.","journal-title":"Br J Dermatol"},{"issue":"2","key":"983_CR106","doi-asserted-by":"publisher","first-page":"188","DOI":"10.2340\/00015555-1672","volume":"94","author":"M Lindberg","year":"2014","unstructured":"Lindberg M, Isacson D, Bingefors K. Self-reported skin diseases, quality of life and medication use: a nationwide pharmaco-epidemiological survey in Sweden. Acta Derm Venereol. 2014;94(2):188\u201391. https:\/\/doi.org\/10.2340\/00015555-1672.","journal-title":"Acta Derm Venereol"},{"issue":"5","key":"983_CR107","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1177\/12034754221119496","volume":"26","author":"RK Andersen","year":"2022","unstructured":"Andersen RK, Bouazzi D, Erikstrup C, Nielsen KR, Burgdorf KS, Bruun MT, et al. The social and psychological impact of acne treatment: a cross-sectional study of blood donors. J Cutan Med Surg. 2022;26(5):485\u201393. https:\/\/doi.org\/10.1177\/12034754221119496.","journal-title":"J Cutan Med Surg"},{"issue":"13","key":"983_CR108","doi-asserted-by":"publisher","first-page":"adv00175","DOI":"10.2340\/00015555-3531","volume":"100","author":"L Misery","year":"2020","unstructured":"Misery L, Ta\u00efeb C, Schollhammer M, Bertolus S, Coulibaly E, Feton-Danou N, et al. Psychological consequences of the most common dermatoses: data from the Objectifs Peau study. Acta Derm Venereol. 2020;100(13):adv00175. https:\/\/doi.org\/10.2340\/00015555-3531.","journal-title":"Acta Derm Venereol"},{"issue":"3","key":"983_CR109","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1007\/s11136-021-02967-2","volume":"31","author":"F Rencz","year":"2022","unstructured":"Rencz F, Mitev AZ, Jenei B, Brodszky V. Measurement properties of the ICECAP-A capability well-being instrument among dermatological patients. Qual Life Res. 2022;31(3):903\u201315. https:\/\/doi.org\/10.1007\/s11136-021-02967-2.","journal-title":"Qual Life Res"},{"issue":"8","key":"983_CR110","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1080\/09546634.2019.1577545","volume":"30","author":"AP Bray","year":"2019","unstructured":"Bray AP, Kravvas G, Skevington SM, Lovell CR. Is there an association between isotretinoin therapy and adverse mood changes? A prospective study in a cohort of acne patients. J Dermatol Treat. 2019;30(8):796\u2013801. https:\/\/doi.org\/10.1080\/09546634.2019.1577545.","journal-title":"J Dermatol Treat"},{"key":"983_CR111","doi-asserted-by":"publisher","first-page":"14733","DOI":"10.2340\/actadv.v104.14733","volume":"104","author":"M Leskel\u00e4","year":"2024","unstructured":"Leskel\u00e4 M, Jokelainen J, Huilaja L, Sinikumpu SP. Adult acne in middle-age: effects on mental health in general population of the Northern Finland Birth Cohort 1966. Acta Derm Venereol. 2024;104:14733. https:\/\/doi.org\/10.2340\/actadv.v104.14733.","journal-title":"Acta Derm Venereol"},{"issue":"4","key":"983_CR112","doi-asserted-by":"publisher","first-page":"419","DOI":"10.5498\/wjp.v6.i4.419","volume":"6","author":"V Ajdacic-Gross","year":"2016","unstructured":"Ajdacic-Gross V, Aleksandrowicz A, Rodgers S, Mutsch M, Tesic A, M\u00fcller M, et al. Infectious, atopic and inflammatory diseases, childhood adversities and familial aggregation are independently associated with the risk for mental disorders: results from a large Swiss epidemiological study. World J Psychiatry. 2016;6(4):419\u201330. https:\/\/doi.org\/10.5498\/wjp.v6.i4.419.","journal-title":"World J Psychiatry."},{"issue":"1","key":"983_CR113","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s00403-020-02074-1","volume":"313","author":"F Esaa","year":"2021","unstructured":"Esaa F, Prezzano J, Pentland A, Ryan WJ. The utility of PROMIS domain measures in dermatologic care. Arch Dermatol Res. 2021;313(1):17\u201324. https:\/\/doi.org\/10.1007\/s00403-020-02074-1.","journal-title":"Arch Dermatol Res"},{"issue":"2","key":"983_CR114","doi-asserted-by":"publisher","first-page":"115","DOI":"10.3109\/09546634.2012.736021","volume":"25","author":"MA Gupta","year":"2014","unstructured":"Gupta MA, Gupta AK, Vujcic B. Increased frequency of attention deficit hyperactivity disorder (ADHD) in acne versus dermatologic controls: analysis of an epidemiologic database from the US. J Dermatol Treat. 2014;25(2):115\u20138. https:\/\/doi.org\/10.3109\/09546634.2012.736021.","journal-title":"J Dermatol Treat"},{"issue":"2","key":"983_CR115","doi-asserted-by":"publisher","first-page":"172","DOI":"10.36849\/jdd.5559","volume":"20","author":"J Hekmatjah","year":"2021","unstructured":"Hekmatjah J, Chat VS, Sierro TJ, Read C, Kassardjian AA, Armstrong AW. Differences in depression and distress between acne patients on isotretinoin vs oral antibiotics. J Drugs Dermatol. 2021;20(2):172\u20137. https:\/\/doi.org\/10.36849\/jdd.5559.","journal-title":"J Drugs Dermatol"},{"issue":"24","key":"983_CR116","doi-asserted-by":"publisher","first-page":"5293","DOI":"10.3390\/nu14245293","volume":"14","author":"M Kostecka","year":"2022","unstructured":"Kostecka M, Kostecka J, Szwed-Gu\u0142aga O, Jackowska I, Kostecka-Jarecka J. The impact of common acne on the well-being of young people aged 15\u201335 years and the influence of nutrition knowledge and diet on acne development. Nutrients. 2022;14(24):5293. https:\/\/doi.org\/10.3390\/nu14245293.","journal-title":"Nutrients"},{"issue":"2","key":"983_CR117","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/j.jaad.2022.10.031","volume":"88","author":"K Kridin","year":"2023","unstructured":"Kridin K, Ludwig RJ. Isotretinoin and the risk of psychiatric disturbances: a global study shedding new light on a debatable story. J Am Acad Dermatol. 2023;88(2):388\u201394. https:\/\/doi.org\/10.1016\/j.jaad.2022.10.031.","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"983_CR118","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1159\/000506627","volume":"236","author":"L Lukaviciute","year":"2020","unstructured":"Lukaviciute L, Ganceviciene R, Navickas P, Navickas A, Grigaitiene J, Zouboulis CC. Anxiety, depression, and suicidal ideation amongst patients with facial dermatoses (acne, rosacea, perioral dermatitis, and folliculitis) in Lithuania. Dermatology. 2020;236(4):314\u201322. https:\/\/doi.org\/10.1159\/000506627.","journal-title":"Dermatology"},{"issue":"4","key":"983_CR119","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1111\/pde.15595","volume":"41","author":"K Miller","year":"2024","unstructured":"Miller K, McKean A, Hand J, Rackley S, Leung JG, LeMahieu A, et al. The occurrence of mental health symptoms in isotretinoin-treated adolescents. Pediatr Dermatol. 2024;41(4):635\u201340. https:\/\/doi.org\/10.1111\/pde.15595.","journal-title":"Pediatr Dermatol"},{"issue":"1","key":"983_CR120","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1111\/bjd.21049","volume":"187","author":"T Paljarvi","year":"2022","unstructured":"Paljarvi T, McPherson T, Luciano S, Herttua K, Fazel S. Isotretinoin and adverse neuropsychiatric outcomes: retrospective cohort study using routine data. Br J Dermatol. 2022;187(1):64\u201372. https:\/\/doi.org\/10.1111\/bjd.21049.","journal-title":"Br J Dermatol"},{"issue":"4","key":"983_CR121","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1001\/jamadermatol.2023.6245","volume":"160","author":"A Shields","year":"2024","unstructured":"Shields A, Barg FK, Begolka WS, Sage K, Druby K, Gondo GC, et al. Identifying core outcome domains in chronic skin disease using the best-worst scaling method. JAMA Dermatol. 2024;160(4):441\u20136. https:\/\/doi.org\/10.1001\/jamadermatol.2023.6245.","journal-title":"JAMA Dermatol"},{"issue":"5","key":"983_CR122","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1111\/bjd.12912","volume":"170","author":"JI Silverberg","year":"2014","unstructured":"Silverberg JI, Silverberg NB. Epidemiology and extracutaneous comorbidities of severe acne in adolescence: a US population-based study. Br J Dermatol. 2014;170(5):1136\u201342. https:\/\/doi.org\/10.1111\/bjd.12912.","journal-title":"Br J Dermatol"},{"issue":"7","key":"983_CR123","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1111\/ced.13919","volume":"44","author":"V Singam","year":"2019","unstructured":"Singam V, Rastogi S, Patel KR, Lee HH, Silverberg JI. The mental health burden in acne vulgaris and rosacea: an analysis of the US National Inpatient Sample. Clin Exp Dermatol. 2019;44(7):766\u201372. https:\/\/doi.org\/10.1111\/ced.13919.","journal-title":"Clin Exp Dermatol"},{"issue":"4","key":"983_CR124","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1016\/j.jaad.2021.01.107","volume":"85","author":"N Ugonabo","year":"2021","unstructured":"Ugonabo N, Love E, Wong PW, Rieder EA, Orlow SJ, Kim RH, et al. Psychiatric disorders and suicidal behavior in patients with acne prescribed oral antibiotics versus isotretinoin: analysis of a large commercial insurance claims database. J Am Acad Dermatol. 2021;85(4):878\u201384. https:\/\/doi.org\/10.1016\/j.jaad.2021.01.107.","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"983_CR125","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1177\/10398562211029955","volume":"30","author":"AS Lappas","year":"2022","unstructured":"Lappas AS, Edwards Suarez L, Tzanetakou V, Morton S, Schofield C, Christodoulou NG. Factors associated with increased suicidality risk following referral for isotretinoin commencement. Australas Psychiatry. 2022;30(1):44\u20138. https:\/\/doi.org\/10.1177\/10398562211029955.","journal-title":"Australas Psychiatry"},{"key":"983_CR126","doi-asserted-by":"publisher","DOI":"10.2196\/45368","volume":"6","author":"K Adkins","year":"2023","unstructured":"Adkins K, Overton PG, Moses J, Thompson A. Investigating the role of upward comparisons and self-compassion on stigma in people with acne: cross-sectional study. JMIR Dermatol. 2023;6:e45368. https:\/\/doi.org\/10.2196\/45368.","journal-title":"JMIR Dermatol."},{"issue":"6","key":"983_CR127","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1001\/jamadermatol.2024.0594","volume":"160","author":"AS Paller","year":"2024","unstructured":"Paller AS, Rangel SM, Chamlin SL, Hajek A, Phan S, Hogeling M, et al. Stigmatization and mental health impact of chronic pediatric skin disorders. JAMA Dermatol. 2024;160(6):621\u201330. https:\/\/doi.org\/10.1001\/jamadermatol.2024.0594.","journal-title":"JAMA Dermatol"},{"issue":"12","key":"983_CR128","doi-asserted-by":"publisher","first-page":"6815","DOI":"10.1111\/jocd.15268","volume":"21","author":"M Szepietowska","year":"2022","unstructured":"Szepietowska M, D\u0105browska A, Nowak B, Skinderowicz K, Wilczy\u0144ski B, Krajewski PK, et al. Facial acne causes stigmatization among adolescents: a cross-sectional study. J Cosmet Dermatol. 2022;21(12):6815\u201321. https:\/\/doi.org\/10.1111\/jocd.15268.","journal-title":"J Cosmet Dermatol"},{"issue":"7","key":"983_CR129","doi-asserted-by":"publisher","first-page":"1768","DOI":"10.1111\/jocd.13207","volume":"19","author":"M Beisert","year":"2020","unstructured":"Beisert M, Pilarczyk K, Zakrzewska M, Pawlaczyk M. Sexual satisfaction and self-esteem in women with acne. J Cosmet Dermatol. 2020;19(7):1768\u201373. https:\/\/doi.org\/10.1111\/jocd.13207.","journal-title":"J Cosmet Dermatol"},{"issue":"1","key":"983_CR130","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.ad.2018.08.001","volume":"110","author":"SE Marron","year":"2019","unstructured":"Marron SE, Gracia-Caza\u00f1a T, Miranda-Sivelo A, Lamas-Diaz S, Tomas-Aragones L. Screening for body dysmorphic disorders in acne patients: a pilot study. Actas Dermosifiliogr (Engl Ed). 2019;110(1):28\u201332. https:\/\/doi.org\/10.1016\/j.ad.2018.08.001.","journal-title":"Actas Dermosifiliogr (Engl Ed)."},{"issue":"2","key":"983_CR131","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1111\/jdv.15954","volume":"34","author":"SE Marron","year":"2020","unstructured":"Marron SE, Miranda-Sivelo A, Tomas-Aragones L, Rodriguez-Cerdeira C, Tribo-Boixaro MJ, Garcia-Bustinduy M, et al. Body dysmorphic disorder in patients with acne: a multicentre study. J Eur Acad Dermatol Venereol. 2020;34(2):370\u20136. https:\/\/doi.org\/10.1111\/jdv.15954.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"1","key":"983_CR132","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1111\/bjd.21021","volume":"187","author":"C Schut","year":"2022","unstructured":"Schut C, Dalgard FJ, Bewley A, Evers AWM, Gieler U, Lien L, et al. Body dysmorphia in common skin diseases: results of an observational, cross-sectional multicentre study among dermatological outpatients in 17 European countries. Br J Dermatol. 2022;187(1):115\u201325. https:\/\/doi.org\/10.1111\/bjd.21021.","journal-title":"Br J Dermatol"},{"key":"983_CR133","doi-asserted-by":"publisher","first-page":"adv6232","DOI":"10.2340\/actadv.v103.6232","volume":"103","author":"BG Tros","year":"2023","unstructured":"Tros BG, Kemperman P, Kuckulus J, Hoekzema R, Vulink NCC. Body dysmorphic disorder and self-esteem in adolescents and young adults with acne vulgaris. Acta Derm Venereol. 2023;103:adv6232. https:\/\/doi.org\/10.2340\/actadv.v103.6232.","journal-title":"Acta Derm Venereol"},{"issue":"4","key":"983_CR134","doi-asserted-by":"publisher","first-page":"485","DOI":"10.2340\/00015555-1998","volume":"95","author":"L Misery","year":"2015","unstructured":"Misery L, Wolkenstein P, Amici JM, Maghia R, Brenaut E, Cazeau C, et al. Consequences of acne on stress, fatigue, sleep disorders and sexual activity: a population-based study. Acta Derm Venereol. 2015;95(4):485\u20138. https:\/\/doi.org\/10.2340\/00015555-1998.","journal-title":"Acta Derm Venereol"},{"issue":"4","key":"983_CR135","doi-asserted-by":"publisher","first-page":"464","DOI":"10.5021\/ad.2016.28.4.464","volume":"28","author":"A Rokowska-Waluch","year":"2016","unstructured":"Rokowska-Waluch A, Pawlaczyk M, Cybulski M, \u017burawski J, Kaczmarek M, Michalak M, et al. Stressful events and serum concentration of substance P in acne patients. Ann Dermatol. 2016;28(4):464\u20139. https:\/\/doi.org\/10.5021\/ad.2016.28.4.464.","journal-title":"Ann Dermatol"},{"issue":"22","key":"983_CR136","doi-asserted-by":"publisher","first-page":"8524","DOI":"10.3390\/ijerph17228524","volume":"17","author":"K Chilicka","year":"2020","unstructured":"Chilicka K, Rogowska AM, Szygu\u0142a R, Adamczyk E. Association between satisfaction with life and personality types A and D in young women with acne vulgaris. Int J Environ Res Public Health. 2020;17(22):8524. https:\/\/doi.org\/10.3390\/ijerph17228524.","journal-title":"Int J Environ Res Public Health"},{"issue":"4","key":"983_CR137","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1177\/0269881118821852","volume":"33","author":"R Brauer","year":"2019","unstructured":"Brauer R, Herrero-Zazo M, Barlow DJ, Gaughran F, Taylor D, Howard LM. Minocycline and the risk of acute psychiatric events in adolescence: a self-controlled case series. J Psychopharmacol. 2019;33(4):466\u201371. https:\/\/doi.org\/10.1177\/0269881118821852.","journal-title":"J Psychopharmacol"},{"issue":"5","key":"983_CR138","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1177\/0269881117743483","volume":"32","author":"M Herrero-Zazo","year":"2018","unstructured":"Herrero-Zazo M, Brauer R, Gaughran F, Howard LM, Taylor D, Barlow DJ. Examining the potential preventative effects of minocycline prescribed for acne on the incidence of severe mental illnesses: a historical cohort study. J Psychopharmacol. 2018;32(5):559\u201368. https:\/\/doi.org\/10.1177\/0269881117743483.","journal-title":"J Psychopharmacol"},{"issue":"3","key":"983_CR139","doi-asserted-by":"publisher","first-page":"732","DOI":"10.3390\/jcm11030732","volume":"11","author":"M Szepietowska","year":"2022","unstructured":"Szepietowska M, D\u0105browska A, Nowak B, Skinderowicz K, Wilczy\u0144ski B, Krajewski PK, et al. Alexithymia in adolescents with acne: association with quality of life impairment and stigmatization. J Clin Med. 2022;11(3):732. https:\/\/doi.org\/10.3390\/jcm11030732.","journal-title":"J Clin Med"},{"key":"983_CR140","doi-asserted-by":"publisher","first-page":"349","DOI":"10.2147\/ccid.S451927","volume":"17","author":"M Szepietowska","year":"2024","unstructured":"Szepietowska M, Stefaniak AA, Krajewski PK, Matusiak \u0141. Anhedonia in acne vulgaris: a cross-sectional study of 104 consecutive acne patients. Clin Cosmet Investig Dermatol. 2024;17:349\u201357. https:\/\/doi.org\/10.2147\/ccid.S451927.","journal-title":"Clin Cosmet Investig Dermatol"},{"issue":"2","key":"983_CR141","doi-asserted-by":"publisher","first-page":"174","DOI":"10.23736\/s2784-8671.24.07754-5","volume":"159","author":"B Bie\u0144","year":"2024","unstructured":"Bie\u0144 B, Krajewski PK, Szepietowski JC. Acne influences life-changing decisions among young adults. Ital J Dermatol Venerol. 2024;159(2):174\u201381. https:\/\/doi.org\/10.23736\/s2784-8671.24.07754-5.","journal-title":"Ital J Dermatol Venerol."},{"key":"983_CR142","doi-asserted-by":"publisher","first-page":"adv5123","DOI":"10.2340\/actadv.v103.5123","volume":"103","author":"F Ballanger","year":"2023","unstructured":"Ballanger F, Claudel JP, Leccia MT, Auffret N, Stromstedt Camerati A, Dufaux PO, et al. Truncal acne in adolescents and young adults: self-reported perception. Acta Derm Venereol. 2023;103:adv5123. https:\/\/doi.org\/10.2340\/actadv.v103.5123.","journal-title":"Acta Derm Venereol"},{"issue":"9","key":"983_CR143","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1001\/jamadermatol.2021.2185","volume":"157","author":"JS Barbieri","year":"2021","unstructured":"Barbieri JS, Fulton R, Neergaard R, Nelson MN, Barg FK, Margolis DJ. Patient perspectives on the lived experience of acne and its treatment among adult women with acne: a qualitative study. JAMA Dermatol. 2021;157(9):1040\u20136. https:\/\/doi.org\/10.1001\/jamadermatol.2021.2185.","journal-title":"JAMA Dermatol"},{"issue":"10","key":"983_CR144","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.36849\/jdd.7713","volume":"22","author":"MM Cartwright","year":"2023","unstructured":"Cartwright MM, Kamen T, Desai SR. The psychosocial burden of skin disease and dermatology care insights among skin of color consumers. J Drugs Dermatol. 2023;22(10):1027\u201333. https:\/\/doi.org\/10.36849\/jdd.7713.","journal-title":"J Drugs Dermatol"},{"issue":"2","key":"983_CR145","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1159\/000526602","volume":"239","author":"PV Chernyshov","year":"2023","unstructured":"Chernyshov PV, Sampogna F, Zouboulis CC, Boffa MJ, Marron SE, Manolache L, et al. Which health-related quality of life items most affect acne patients? Dermatology. 2023;239(2):267\u201372. https:\/\/doi.org\/10.1159\/000526602.","journal-title":"Dermatology"},{"issue":"1","key":"983_CR146","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/s13555-018-0224-7","volume":"8","author":"G Fabbrocini","year":"2018","unstructured":"Fabbrocini G, Cacciapuoti S, Monfrecola G. A qualitative investigation of the impact of acne on health-related quality of life (HRQL): development of a conceptual model. Dermatol Ther (Heidelb). 2018;8(1):85\u201399. https:\/\/doi.org\/10.1007\/s13555-018-0224-7.","journal-title":"Dermatol Ther (Heidelb)."},{"issue":"7","key":"983_CR147","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1111\/jdv.19781","volume":"38","author":"T Marty","year":"2024","unstructured":"Marty T, Khadar M, Autelitano L, Baissac C, Mebarki A, Texier N, et al. Patients\u2019 testimonies, feelings, complaints and emotional experiences with dermatoses on open social media: the French infodemiologic patient\u2019s free speech study. J Eur Acad Dermatol Venereol. 2024;38(7):1373\u201382. https:\/\/doi.org\/10.1111\/jdv.19781.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"3","key":"983_CR148","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1111\/jdv.14719","volume":"32","author":"JC Szepietowski","year":"2018","unstructured":"Szepietowski JC, Wolkenstein P, Veraldi S, Tennstedt D, Machovcov\u00e1 A, Delarue A. Acne across Europe: an online survey on perceptions and management of acne. J Eur Acad Dermatol Venereol. 2018;32(3):463\u20136. https:\/\/doi.org\/10.1111\/jdv.14719.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"8","key":"983_CR149","doi-asserted-by":"publisher","first-page":"1847","DOI":"10.1007\/s13555-022-00768-0","volume":"12","author":"J Tan","year":"2022","unstructured":"Tan J, Beissert S, Cook-Bolden F, Chavda R, Harper J, Hebert A, et al. Evaluation of psychological wellbeing and social impact of combined facial and truncal acne: a multi-national, mixed-methods study. Dermatol Ther (Heidelb). 2022;12(8):1847\u201358. https:\/\/doi.org\/10.1007\/s13555-022-00768-0.","journal-title":"Dermatol Ther (Heidelb)."},{"issue":"5","key":"983_CR150","doi-asserted-by":"publisher","first-page":"642","DOI":"10.23736\/s0392-0488.18.05920-5","volume":"155","author":"S Tavecchio","year":"2020","unstructured":"Tavecchio S, Barbareschi M, Veraldi S. What Italians think about acne: results of a survey on 2327 acne patients and their mothers. G Ital Dermatol Venereol. 2020;155(5):642\u20135. https:\/\/doi.org\/10.23736\/s0392-0488.18.05920-5.","journal-title":"G Ital Dermatol Venereol"},{"issue":"3","key":"983_CR151","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1177\/1203475418756379","volume":"22","author":"C McLellan","year":"2018","unstructured":"McLellan C, Frey MP, Thiboutot D, Layton A, Chren MM, Tan J. Development of a comprehensive quality-of-life measure for facial and torso acne. J Cutan Med Surg. 2018;22(3):304\u201311. https:\/\/doi.org\/10.1177\/1203475418756379.","journal-title":"J Cutan Med Surg"},{"issue":"6","key":"983_CR152","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1111\/bjd.18005","volume":"181","author":"AF Klassen","year":"2019","unstructured":"Klassen AF, Lipner S, O\u2019Malley M, Longmire NM, Cano SJ, Breitkopf T, et al. Development of a new patient-reported outcome measure to evaluate treatments for acne and acne scarring: the ACNE-Q. Br J Dermatol. 2019;181(6):1207\u201315. https:\/\/doi.org\/10.1111\/bjd.18005.","journal-title":"Br J Dermatol"},{"key":"983_CR153","unstructured":"United States Food and Drug Administration. Acne vulgaris: establishing effectiveness of drugs intended for treatment. 2018. https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/acne-vulgaris-establishing-effectiveness-drugs-intended-treatment. Accessed 12 Dec 2024."},{"issue":"9","key":"983_CR154","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1016\/j.jclinepi.2015.03.023","volume":"68","author":"K Kroenke","year":"2015","unstructured":"Kroenke K, Monahan PO, Kean J. Pragmatic characteristics of patient-reported outcome measures are important for use in clinical practice. J Clin Epidemiol. 2015;68(9):1085\u201392. https:\/\/doi.org\/10.1016\/j.jclinepi.2015.03.023.","journal-title":"J Clin Epidemiol"},{"issue":"6","key":"983_CR155","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.1007\/s11136-021-03030-w","volume":"31","author":"VL Taliercio","year":"2022","unstructured":"Taliercio VL, Snyder AM, Biggs AM, Kean J, Hess R, Duffin KC, et al. Clinicians\u2019 perspectives on the integration of electronic patient-reported outcomes into dermatology clinics: a qualitative study. Qual Life Res. 2022;31(6):1719\u201325. https:\/\/doi.org\/10.1007\/s11136-021-03030-w.","journal-title":"Qual Life Res"},{"issue":"6","key":"983_CR156","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1080\/000155598442773","volume":"78","author":"MA Gupta","year":"1998","unstructured":"Gupta MA, Johnson AM, Gupta AK. The development of an Acne Quality of Life scale: reliability, validity, and relation to subjective acne severity in mild to moderate acne vulgaris. Acta Derm Venereol. 1998;78(6):451\u20136. https:\/\/doi.org\/10.1080\/000155598442773.","journal-title":"Acta Derm Venereol"},{"issue":"Suppl 1","key":"983_CR157","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1159\/000246015","volume":"195","author":"AM Layton","year":"1997","unstructured":"Layton AM, Seukeran D, Cunliffe WJ. Scarred for life? Dermatology. 1997;195(Suppl 1):15\u201321. https:\/\/doi.org\/10.1159\/000246015.","journal-title":"Dermatology"},{"issue":"3","key":"983_CR158","first-page":"333","volume":"13","author":"A Alexis","year":"2014","unstructured":"Alexis A, Daniels SR, Johnson N, Pompilus F, Burgess SM, Harper JC. Development of a new patient-reported outcome measure for facial acne: the Acne Symptom and Impact Scale (ASIS). J Drugs Dermatol. 2014;13(3):333\u201340.","journal-title":"J Drugs Dermatol"},{"issue":"1","key":"983_CR159","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/s0190-9622(97)70210-x","volume":"37","author":"RT Anderson","year":"1997","unstructured":"Anderson RT, Rajagopalan R. Development and validation of a quality of life instrument for cutaneous diseases. J Am Acad Dermatol. 1997;37(1):41\u201350. https:\/\/doi.org\/10.1016\/s0190-9622(97)70210-x.","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"983_CR160","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1097\/00005650-199206000-00002","volume":"30","author":"JE Ware Jr","year":"1992","unstructured":"Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992;30(6):473\u201383.","journal-title":"Med Care"},{"issue":"3","key":"983_CR161","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1097\/00005650-199603000-00003","volume":"34","author":"J Ware Jr","year":"1996","unstructured":"Ware J Jr, Kosinski M, Keller SD. A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med Care. 1996;34(3):220\u201333. https:\/\/doi.org\/10.1097\/00005650-199603000-00003.","journal-title":"Med Care"},{"key":"983_CR162","unstructured":"EuroQol Research Foundation. EQ-5D-5L User Guide. 2019. https:\/\/euroqol.org\/information-and-support\/documentation\/user-guides\/. Accessed 7 Nov 2024."},{"key":"983_CR163","doi-asserted-by":"publisher","unstructured":"WHOQOL Group. Development of the World Health Organization WHOQOL-BREF quality of life assessment. Psychol Med. 1998;28(3):551\u20138. https:\/\/doi.org\/10.1017\/s0033291798006667.","DOI":"10.1017\/s0033291798006667"},{"issue":"4","key":"983_CR164","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1037\/1076-8998.10.4.363","volume":"10","author":"ACH Schat","year":"2005","unstructured":"Schat ACH, Kelloway EK, Desmarais S. The Physical Health Questionnaire (PHQ): construct validation of a self-report scale of somatic symptoms. J Occup Health Psychol. 2005;10(4):363\u201381. https:\/\/doi.org\/10.1037\/1076-8998.10.4.363.","journal-title":"J Occup Health Psychol"},{"issue":"5","key":"983_CR165","doi-asserted-by":"publisher","first-page":"328","DOI":"10.3109\/07853890109002086","volume":"33","author":"H Sintonen","year":"2001","unstructured":"Sintonen H. The 15D instrument of health-related quality of life: properties and applications. Ann Med. 2001;33(5):328\u201336. https:\/\/doi.org\/10.3109\/07853890109002086.","journal-title":"Ann Med"}],"container-title":["American Journal of Clinical Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40257-025-00983-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40257-025-00983-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40257-025-00983-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T08:50:58Z","timestamp":1769849458000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40257-025-00983-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,24]]},"references-count":165,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["983"],"URL":"https:\/\/doi.org\/10.1007\/s40257-025-00983-3","relation":{},"ISSN":["1175-0561","1179-1888"],"issn-type":[{"value":"1175-0561","type":"print"},{"value":"1179-1888","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,24]]},"assertion":[{"value":"21 August 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 October 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The development of this manuscript and the open access fee were supported by Sanofi.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"A.M.L. has served as an advisory board member and consultant for Alliance, Almirall, Galderma, Glenmark, Eligo Bioscience, L\u2019Oreal, La Roche-Posay, Novartis, and Viatris; provided unrestricted educational talks for Almirall, Beiersdorf, Galderma, LEO Pharma, L\u2019Oreal, and La Roche-Posay; and received sponsorship to attend educational dermatology meetings from Almirall, LEO Pharma, and L\u2019Oreal. V.B. has served as an advisory board member for AbbVie, Beiersdorf, Cantabria Labs, Galderma, Ganassini, General Topics, L\u2019Oreal, Menarini, Mylan, Novartis, Sanofi, and UCB; received research grants from AbbVie and Ganassini; and received speaker\u2019s honoraria from AbbVie, Beiersdorf, Cantabria Labs, Galderma, Ganassini, General Topics, L\u2019Oreal, Menarini, Mylan, Novartis, and UCB. V.D. and E.P. are employees of Sanofi. J.K.L.T. has served as an advisory board member for Abbott, Cutera, Derm-Biome, Galderma, Sanofi, and Sun Pharma; a consultant for Bausch Health, Boots Walgreens, Galderma, Linio Biotech, L\u2019Oreal, and Pierre Fabre; an independent contractor for Novartis and Pfizer; an investigator for Cutera and Galderma; a speaker for Bausch Health, Galderma, L\u2019Oreal, and Pierre Fabre; and is a co-copyright holder of the Comprehensive Acne Quality of Life Scale (CompAQ), with usage fees donated to the Acne Core Outcomes and Research Network (ACORN).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"Data available within the article or its supplementary materials\n                      .","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data availability"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}},{"value":"All authors participated in the conception and design of the systematic review, the analysis and interpretation of the results, the drafting and critical review of the manuscript, and gave final approval of the version for publication. All authors agree to be accountable for the accuracy and integrity of all aspects of the published work.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author contributions"}}]}}